Reducing the GI Risks of Antiplatelet Therapy and NSAID Use
Published: October 03, 2008
![Science News on light gray background](/-/media/PHD-Images/Science-News/science_news_default.jpg?h=343&iar=0&mh=515&mw=515&w=515)
- There is uncertainty about how to best prevent bleeding complications in patients receiving antiplatelet therapy and NSAIDs.
- Patients are on these agents for longer periods than in the past, increasing their time of risk.
- Evaluation of the risk profile for each patient is critical.